Loading clinical trials...

Exercise, Brain, Cognition, OMICs, Molecular Markers and Functionality in People at Risk of Mild Cognitive Impairment | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT03923712

Exercise, Brain, Cognition, OMICs, Molecular Markers and Functionality in People at Risk of Mild Cognitive Impairment

This project aims to examine the effect of a 5-month period supervised exercise intervention on brain, cognition, OMICs, Molecular Markers and functional status in older people at risk of mild cogniti...

Lead sponsor: University of Cadiz•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Related studies

RECRUITINGNA

Feasibility Study of 'SuperBrain BOOM' for Mild Cognitive Impairment Patients

NCT07101380 · Mild Cognitive Impairment (MCI)

RECRUITING

The Swedish BioFINDER - Preclinical AD Study

NCT06121544 · Alzheimer Disease, Mild Cognitive Impairment, and more

RECRUITINGPhase 1/2

Sense4Safety Intervention

NCT07220668 · Mild Cognitive Impairment

RECRUITINGPhase 2

Novel Augmentation of DAOIB and Antioxidant for Early Dementia

NCT06467539 · Alzheimer Disease, Mild Cognitive Impairment

RECRUITINGEARLY Phase 1

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

NCT04123314 · Depressive Symptoms, Depression, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 27, 2021Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment98

Start dateJan 2018

Last updatedApr 27, 2021

Condition

Mild Cognitive Impairment Alzheimer Dementia

Locations shown

University of Cádiz

Cadiz

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 27, 2021Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions